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Symptomatic Rathke cleft cysts (RCCs) are rarely detected in neuroradiological 
screening and are less commonly found in children than in adults. However, when 
RCCs are observed in children, it is important to carefully distinguish a RCC from a 
cystic craniopharyngioma (CP) even if surgically treated or conservatively followed-up. 
Methods 
We conducted a retrospective review of clinical data from 11 patients with symptomatic 
RCCs whose ages were under 18 years and compared the data to data from 15 age- 
and sex-matched patients with cystic CP who were treated at our institute. 
Results 
The mean age of the patients with RCCs was 12.2 years (range, 6-18). There were 6 
males and 5 females. As initial symptoms, nine patients presented with headache, while 
2 each had impaired visual function, diabetes insipidus, and activity loss. The 14 
patients with CP suffered from impaired visual function. Magnetic resonance imaging 
(MRI) mainly showed hyperintensity on T1-weighted images (WIs) and hypointensity on 
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T2-WI in patients with RCC. However, patients with CP had characteristic hyperintensity 
on T2-WI. The average maximum diameter of the RCCs was 19.0 mm on average 
(range, 8-33 mm). The RCCs were thus significantly smaller than CPs (34.9mm, range 
21-54 mm). The RCCs were usually oval or dumbbell-shaped and regular in 
appearance, while the larger CPs were lobular and irregular. A preoperative 
endocrinological evaluation revealed insufficiencies in 4 axes in 5 patients with RCC. 
Postoperative endocrinological status improved in 3 patients, remained unchanged in 3, 
and worsened in 1. The gonadotropin axis was damaged in a majority (9) of the patients 
with CP preoperatively. Postoperative evaluation revealed deficits in 5 axes in 14 
patients with CP, which is a significantly different trend than observed in patients with 
RCC. Eight patients underwent surgical procedures (transsphenoidal surgery (TSS) in 4, 
craniotomy in 4). Two of these patients experienced a recurrence of the cysts. One of 
these patients subsequently underwent two craniotomies followed by radiation and 
other underwent TSS. Among the 3 conservatively-treated patients, two experienced a 
transient worsening of their symptoms along with cyst enlargement. However, none of 
the 3 conservatively-treated patients required an operation. 
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Conclusions 
When RCCs become symptomatic in children, the most common symptom they lead to 
is headache. The cysts are commonly small, regular, and oval in shape. Hypointensity 
of cyst contents on MRI is a characteristic of RCCs, which distinguishes them from CPs. 
Surgical intervention can be effective and lead to the relief of symptoms without a high 
rate of complications. However, there seems to be a relatively high recurrence rate 
following surgery. Thus, if the patient’s symptoms remain minor, the surgical treatment 




   Rathke cleft cysts (RCCs) are the most common non-neoplastic cystic lesions in the 
sellar and the suprasellar regions. Their cyst walls are composed of epithelial cells and 
there is fluid with high protein concentration inside the cyst [1,2]. RCCs are found to 
arise from embryonic remnants of Rathke’s pouch and are typically located at the pars 
intermedia between the adenohypophysis and the neurohypophysis [3,4]. Although they 
are reported in as many as 3-22% of all autopsy studies, they are seldom symptomatic 
during life [5,6]. The most common clinical symptoms associated with RCCs are 
headache, impaired visual function, and endocrinological insufficiency [7,8]. RCCs can 
also cause delayed or precocious puberty, amenorrhea/galactorrhea, growth retardation, 
weight gain, and hypogonadism [9-11]. As the peak age of patients presenting with 
RCCs symptoms is typically between 30 and 50 years, it is unusual to detect RCCs by 
magnetic resonance imaging (MRI) in asymptomatic children [7,12,13]. In addition, 
even among symptomatic patients, the rate of RCC prevalence is much lower in 
children compared to adults [14,15].  
   The radiological findings of RCCs are sometimes reported to be similar to those of 
cystic craniopharyngioma (CP). One should thus be careful to distinguish RCCs from 
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cystic CPs, as the two are quite different with regards to surgical procedures available 
for treatment, complications, and prognosis. It is well known that patients with CP 
require total removal of the tumor including the cyst wall. The rate of postoperative 
complications, such as hypopituitarism, diabetes insipidus, and recognition insufficiency 
is remarkably high [7,16]. Therefore, indications for the surgical treatment of 
symptomatic pituitary cysts should include histological confirmation of the surgical 
specimen, as well as confidence the surgery will lead to the relief of the symptoms. 
When an asymptomatic RCC is discovered in children, it is also important to follow up 
with radiological imaging and to carefully monitor the patient’s clinical symptoms and 
signs [17]. 
   The aim of this study is to review the clinical statuses of children with symptomatic 
RCCs treated either surgically or conservatively and to compare them with 
characteristics of children with cystic CPs. In order to do so, we will review the patients’ 
symptoms, radiological and endocrinological findings, operative reports, recurrence 
rates, and outcomes.  
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Methods 
   This study was approved by the Kanazawa University Institutional Review Board. In 
this retrospective clinical study, 11 patients with RCC and 15 patients with cystic CP 
who consulted to Kanazawa University Hospital between 1997 and 2015 were enrolled. 
The patients were younger than 18 years of age at the onset of their symptoms. Both 
RCCs and cystic CPs were clinically diagnosed based on MRI findings. We considered 
the following items obtained from the patients’ clinical charts: sex, age, symptoms 
including headache, impaired visual function, and radiological evaluation, 
endocrinological insufficiencies, operative reports, recurrence, outcomes, and follow-up 
periods. Postoperative outcomes were classified as: improved with relief of preoperative 
symptoms, unchanged with the continuation of symptoms, or worsening with 
deterioration of symptoms and/or occurrence of new postoperative symptoms. 
Neuroradiological evaluation 
   A 3.0-Tesla MRI (GE Health care Japan Corp., Tokyo) was used to obtain horizontal, 
coronal, and sagittal images before and after gadolinium administration. The 
characteristics of the cysts (maximum diameter, shape, signal intensity of the cyst 
content, location, enlargement upon follow-up, and enhancement after administration of 
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contrast medium) were evaluated by MRI on both T1- and T2-weighted images (WIs). 
RCCs diagnosed neuroradiologically had to meet all of the following conditions to 
qualify for a conservative treatment course; 1) the cystic lesion is oval or 
dumbbell-shaped and is located in the sellar or suprasellar region, 2) the cystic lesion is 
circumferentially surrounded by the normal pituitary gland, and 3) the cyst wall has little 
or no enhancement, has no signs of invasion, and has no calcification [18]. Cystic CPs 
are considered those in which the cystic portion predominantly accounted for at least 
60% of the tumors. This diagnosis was made using MRI [19]. 
Endocrinological evaluation 
   An endocrinological examination was performed preoperatively, and included 
measurements of plasma growth hormone (GH), insulin-like growth factor-I, prolactin, 
adrenocorticotrophic hormone (ACTH), cortisol, thyroid-stimulating hormone (TSH), 
triiodothyronine, thyroxin, luteinizing hormone, follicle stimulating hormone, and 
anti-diuretic hormone (ADH) levels. Insulin, corticotropin-releasing hormone, 
thyrotropin-releasing hormone, and luteinizing hormone-releasing hormone loading 
tests were carried out postoperatively to evaluate the reserve capacity of each hormone 
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tested preoperatively. Diabetes insipidus (DI) was considered to be present in patients 
with polydipsia and polyuria (total amount of urine volume per day greater than 3000ml 
with urine specific gravity of less than 1.005), and in those who used 
1-desamino-8-D-arginine vasopressin (DDAVP). A water-deprivation test and/or 
hypertonic saline infusion test were performed to diagnose of postoperative permanent 
DI in patients [20]. A pediatric endocrinologist evaluated the results of the pituitary 
functional examinations. 
Surgical procedures 
   The patients treated using surgical operations underwent transsphenoidal surgery 
(TSS), craniotomy, or both. TSS was performed using a microscope (1997-2004) or an 
endoscope (2005-2015). On the other hand, craniotomy was performed using a 
pterional or interhemispheric approach and a microscope. Patients with RCCs were 
treated with a partial cyst wall removal and complete aspiration of the cyst contents. 
Total removal of the cyst wall was attempted in all patients with CPs. When craniotomy 
was used in these patients a pterional or interhemispheric approach was selected 
based on tumor size and the direction of its extension. In contrast, when the patients 
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were treated by TSS, the procedure was performed using a microscope (1997-2004) or 
an endoscope (2005-2015), as described above for patients with RCC. Recurrence was 
defined as a re-accumulation of the fluid inside the cyst by MRI evaluation during the 
postoperative follow-up period. Pathological analysis of the resected cyst wall was 
performed to confirm the final diagnosis by a pathologist. 
Statistical analysis 
     Chi-squared tests were used to compare the two patient groups. Mann-Whitney 
U-tests were used to make comparisons between the patients’ ages and the maximum 
diameters of their cysts. These statistical analyses were performed using Microsoft 




   A summary of the characteristics of the patients in our study with pediatric RCCs is 
shown in Table 1, while Table 2 summarized the results of comparisons between 
patients with RCCs and those with cystic CPs.  
Patient characteristics and clinical symptoms 
   Of the 11 patients with RCC that were reviewed, 6 were male and 5 were female. 
The mean age of these patients was 12.2 years (range, 5-18). Of the 15 patients with 
CP that were reviewed, 8 were male and 7 were female. The mean age of these 
patients was 9.3 years (range, 4-18). Both groups had similar sex distributions  (p = 
0.951). In addition, the mean ages of the two groups were not significantly different (p = 
0.071). Nine (82%) of the patients with RCCs presented with headache as their initial 
symptom (p < 0.001), while 2 (18%) each first complained of impaired visual function, 
diabetes insipidus, and activity loss (Tables 1 and 2). All the patients who suffered from 
headaches were relieved of their symptoms postoperatively without the use of 
medication. Visual impairment was completely diminished in the two patients initially 
complaining of the symptom. Postoperative endocrinological symptoms improved in 2 
patients (partial DI in patient 4, and fatigue and anorexia in patient 6), were unchanged 
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in 1 patient (growth retardation and loss of activity in patient 5), and worsened in 1 
patient (permanent DI in patient 1) (Table 1). Meanwhile, 14 out of 15 (93%) of the 
patients with cystic CPs had the initial symptom of impaired visual function (p < 0.001). 
In addition, endocrinological insufficiencies, such as growth retardation, and headache 
were initial symptoms in 2 patients (13%) each (Table 2). Impaired visual function was 
remarkably improved after surgical decompression of the optic nerves. Although 
headaches were relieved without medication, the endocrinological statuses of 14 out of 
15 (93%) of the patients deteriorated remarkably. These patients were required to 
undergo hormonal replacement therapy following their surgeries. 
Neuroradiological findings 
   Patients with RCCs had an averaged maximum cyst diameter of 19.0 mm (range, 
8-33 mm). The cysts were characterized by hyper-intense signals on T1-WI in 7 patients 
(p = 0.058). Of these patients, 1 had a hyper-intense cyst and 6 had hypo-intense cysts 
on T2-WI. In addition, 4 patients had cysts that were hypo-intense on T1-WI and 
hyper-intense on T2-WI (p = 0.391). Although 6 of the patients had cysts that grew in 
size during the observation period, these enlargements were insignificant. The cysts 
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were largely oval or dumbbell-shaped in all of the patients with RCCs (p < 0.001). 
Seven patients had cysts that were located in the sellar region and had suprasellar 
extensions and 4 had cysts whose locations were restricted to the suprasellar region. 
Neither calcification nor hydrocephalus was found in any of the patients (Table 2). 
Representative MRIs of RCCs are shown in Figure 1. 
   The cystic CPs observed had an average maximum diameter of 34.9 mm (range, 
21-54 mm) and were significantly larger than RCCs (p < 0.001). Four patients had cysts 
that were hyper-intense on T1-WI, 3 patients had iso-intense cysts, and 8 had 
hypo-intense cysts. All of the patients had cysts that were hyper-intense on T2-WI (p < 
0.001). Five patients had cysts that were regular and oval, and 10 had irregular lobular 
cysts (Table 2). The diameters of the irregularly-shaped cysts were significantly larger 
than those of regularly-shaped ones (39.7 vs. 25.4 mm, p < 0.001). All of the cysts had 
calcification on their walls (p < 0.001). Six patients had cysts in the sellar region that 
extended into suprasellar regions and 9 had suprasellar cysts. The distribution of the 
cysts in these patients was thus not significantly different from that observed in patients 
with RCCs (p = 0.234) (Table 2). In 5 patients, hydrocephalus was detected, which is 
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significantly different when compared to patients with RCCs (p = 0.033). All of these 
patients had obstructive hydrocephalus at the foramen of Monro, which was relieved 
after tumor removal. However, the maximum diameters of the cystic CPs were 
significantly larger in patients with hydrocephalus (43.5 mm) compared to those in 
patients without hydrocephalus (29.3 mm) (p = 0.001). Representative MRI results for 
these CPs are shown in Figure 2. 
Endocrinological findings 
   Preoperative endocrinological evaluation in patients with RCCs revealed 
insufficiencies in 4 axes and in 5 patients. Two patients had decreases in both cortisol 
and ACTH at baseline and a hypo-response to CRH loading postoperatively (patients 1 
and 4). In one patient with ACTH solo-decline (patient 6) who had fatigue and anorexia 
as a symptom, the ACTH insufficiency recovered and his symptoms were relieved after 
surgical intervention. However, in another patient with declines in both ACTH and ADH 
(patient 4), the ACTH insufficiency did not improve after surgery. Two patients (patient 1 
and 5) had impairments in TSH secretion before surgery, which were not improved 
preoperatively. Although GH levels were low in 2 patients preoperatively, one patient 
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with GH solo-decline (patient 3) had no symptoms related to GH insufficiency, which 
was diagnosed with hormones loading test including insulin and normalized after 
surgery. In the patient with declines in both GH and TSH secretion (patient 5) before 
surgery, neither hormonal insufficiency was improved following surgery. While ADH was 
lower in 2 patients who had manifestations of DI preoperatively, only one of the patients 
with ADH decline (patient 4) had symptoms of polydipsia and polyuria. A hypertonic 
saline infusion test revealed increased urine osmolality in this patient. This patient was 
diagnosed as having partial central DI, which recovered postoperatively with 
diminishment of symptoms. The patient with deficits in ADH secretion as well as in 
another axis before surgery (patient 1) revealed no improvement in the hormonal 
insufficiencies after surgery. He was diagnosed as central diabetes after a water 
deprivation test with the presence of polydipsia and hypotonic polyuria. Transient DI 
occurred in 2 patients (patients 3 and 7) postoperatively (Table 1). 
   In endocrinological evaluation of CPs, preoperative abnormalities were observed in 
11 patients (73%). This frequency was not significantly different in patients with CP 
compared to those with RCCs (p = 0.149). Three patients had impairments in ACTH 
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(20%), 8 had deficits in GH (53%), and 9 had deficient gonadotropin secretion (60%). 
The number of patients with preoperative impairment of gonadotropin was significantly 
different in patients with CP compared to those with RCC (p = 0.002). Fourteen patients 
had hormonal abnormalities postoperatively (p < 0.001). The impaired secretions of 
pituitary hormones were as follows: gonadotropin in 10 patients (67%), GH in 13 (87%), 
TSH in 11 (67%), ACTH in 12 (80%), and prolactin in 5 (33%). The rates of all these 
impairments in hormonal function were significantly higher in patients with CPs 
compared to those with RCCs (Table 2). Permanent DI occurred in 9 (60%) of these 
patients. These patients were treated with routine administration of proper amounts of 
DDAVP. The number of patients with permanent DI was remarkably higher in the CP 
group than in patients with RCCs (p = 0.006) (Table 2). Decreased GH, TSH, and ACTH 
were replaced by a pediatric endocrinologist. 
Operations 
   Eight patients with RCCs underwent surgeries. Four of these patients had TSS and 
4 had craniotomies. The 3 patients who did not undergo surgery were treated 
conservatively. TSSs were routinely performed with partial cyst wall resection and 
 17 
complete aspiration of cyst contents under a microscope (patients 1-5) or an endoscope 
(patiens 6,7,11). The patients who underwent TSS were 10 to 15 years of age. 
Therefore, their nasal cavities were not significantly smaller than those of adults. As a 
result, the TSSs were performed without any complications in patients with RCCs (Table 
1).  
   All 15 patients with CP underwent surgeries. Eight of these patients had 
craniotomies (interhemispheric approach in 6, pterional approach in 2) and 7 had TSS. 
Differences in the use of surgical approaches were not significant between RCCs and 
cystic CPs (Table 2). Sellar tumors with suprasellar extensions were treated using TSS 
and tumors that were located in the suprasellar and did not extend into the intrasellar 
region were removed using craniotomies. Cyst contents were completely evacuated 
and the cyst walls were removed as much as possible unless the cyst wall adhered to 
adjacent vascular or neural structures. 
Pathological findings 
   Pathological examination of the cyst wall was performed in all 8 patients. Five cysts 
were diagnosed as RCCs, as indicated by the presence of columnar or cuboidal cells 
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with microvilli lining the epithelium. Three patients had surgical specimens with 
microscopic bleeding from granulations on the cyst wall, five had an invasion of 
inflammatory cells, such as lymphocytes, and three had collagen fibers infiltration. 
These pathological features revealed the presence of acute- or chronic- phase 
inflammation, which had spread around the cyst wall. Patient 1 in the present study 
encountered re-accumulation of the cyst contents twice (Fig. 3A-C). All procedures for 
this patient, including the first transcranial surgery were performed without neurological 
complications. A surgical specimen of the cyst wall revealed typical squamous 
metaplasia, which was reported to mimic to papillary type of CP (Fig. 3D). 
   Pathological examinations of the cystic CPs in our study revealed typical 
adamantinomatous type of CP in all of the cases. 
Recurrence on follow-up 
   In this study, patients with RCCs were followed up for 12-152 months. Two patients 
had a recurrence of RCCs (25.0%). One patient (patient 1) was treated with 
craniotomies after both recurrences and was subsequently treated with radiation (Fig. 3). 
The other patient (patient 6) had TSS upon cyst recurrence. During the follow-up of the 
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three conservatively-treated patients, two patients manifested a transient worsening of 
their symptoms with mild cyst enlargement. However, as the cyst enlargement did not 
progress in these patients; all 3 conservatively-treated patients continued to be treated 
the same way without undergoing an operation. 
   Six of the 15 patients with CPs had recurrences (40%). This difference of recurrence 
rates between the RCC group and the CP group was not a significant (p = 0.184), 
although the numbers of patients of both groups were limited (Table 2). All 6 patients 
underwent a second operation and 5 were treated with radiation. Three patients 
underwent surgery followed by radiation for the removal of their tumors and any 
remaining residues (20%). None of the patients were conservatively treated when 
follow-up MRI detected a recurrence of their tumors. 
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Discussion 
   Although RCC is rarely symptomatic in children, it is important to distinguish RCCs 
from cystic CP, as their treatment and prognosis are quite different from each other 
[7,16]. Even with pathological examination of the surgical specimen, it is difficult to 
distinguish RCCs from cystic CPs in some cases. This is because squamous 
metaplasia of the epithelial cells is considered to be a transitional form of progression 
from RCC to CP [21,22]. Therefore, the clinical characteristics of RCCs should be 
carefully considered in children. The symptoms, radiological and endocrinological 
evaluation, surgical considerations, and outcomes of these patients should then be 
compared to those of patients with CP. Although many authors reported a clinical 
comparison of RCCs with cystic CPs in all age group [23,24], this study is the first to 
offer the clinical comparison peculiar to children to elucidate the differences in the 
diagnosis and management. 
   The characteristic neuroradiological findings in patients with RCCs are summarized 
below and compared to those of patients with cystic CPs; 1) The maximum diameters of 
the cysts were relatively smaller in RCCs. 2) Although the RCCs were regularly oval or 
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dumbbell-shaped, the cystic CPs were superiorly lobulated, irregular, and extended. 3) 
60% of the patients with RCCs had hypo-intense signals on T2-WI MRI, while all 
patients with cystic CP had hyper-intense signals. 4) The RCCs are mainly intrasellar, 
but 36% of the cases and cysts that were located in the suprasellar region. This was a 
remarkably higher rate compared to that observed in RCCs in adults. These RCCs 
could not be definitively differentiated from CPs by preoperative imaging [15]. 5) No 
RCCs had calcification, while calcification was observed in all cystic CPs [16,25]. 6) No 
hydrocephalus was found in patients with RCCs, while 5 patients with cystic CPs had 
obstructive hydrocephalus. Our results also suggested that cystic CPs with 
hydrocephalus were significantly larger than those without hydrocephalus and were 
enough to occlude the foramen of Monro. 
   The regularly oval shape of the RCCs, their hypo-intense signal on T2-WI MRI, and 
the lack of calcification on their cyst walls are important to note during preoperative 
diagnosis, as it would be of great benefit to neurosurgeons to distinguish RCCs from CP 
and avoid unnecessary cyst wall removal [7]. Although cystic CPs are typically of the 
adamantinomatous subtype as shown in our study, it is reported that some CPs in 
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children do not have calcification [26]. The signal intensities of RCCs on T1-WI and 
T2-WI MRI for RCC are highly variable and are reported to correlate with the nature of 
the cyst contents [27,28]. In addition, although the content of most RCCs display a 
homogenous signal up to 40% of cases contain waxy intracystic nodules, which lead to 
very hypointense signals on T2-WI. These nodules are important key findings in the 
diagnosis of RCC [7,29]. In contrast, T2-WI hyperintensities were found in all of the 
patients with CP in our study, despite the existence of a variety of signal distributions on 
T1-WI. Therefore, the findings of hypointensity and heterogeneity on T2-WI are 
considered to be important in distinguishing RCCs from CPs [15,30].  
   Preoperative endocrinological impairment of RCCs in children occurred in one axis 
in 2 patients and in two axes in 3 patients with RCCs. Postoperative evaluation showed 
improvements in 2 patients with one axis impairment and no change in 3 patients with 
two-axis impairment. It was noteworthy that no patient demonstrated postoperative 
endocrinological deterioration, except for transient delayed DI, which was observed in 
patients 3 and 7. Meanwhile, preoperative endocrinological impairment occurred in 10 
(67%) out of 15 patients with cystic CP. Subsequently, postoperative endocrinological 
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evaluation demonstrated remarkable deterioration in 14 patients (93%). These results 
were quite different from those observed in patients with RCCs. No newly developed 
postoperative permanent DI was found in RCCs, but 9 patients (60%) had permanent DI 
in cystic CPs. This significant difference in postoperative endocrinological status is 
probably due to the procedure to remove as much of the cyst as possible in patients 
with CPs. However, recent advances in the administration of hormonal replacement can 
make such removal procedures possible. 
   The standard partial excision of the cyst wall and complete aspiration of cyst 
contents are considered to result in total resolution of RCCs, while minimizing 
complications [12,13,31]. Aho reported on the surgical treatment of a series of RCCs in 
adults. The initial gross total resection rate was 97% and the recurrence rate was 18% 
at 5 years [12]. Zada reported on a series of RCCs in children, which were treated 
surgically and had a recurrence rate of 11% at 3 years [15]. Jahangiri presented their 
RCC series and reported that the recurrence rates for the adult patients and the 
pediatric patients were similar, at 12% and 14%, respectively [14]. Some authors 
believe that there is a positive association between squamous metaplasia of the cyst 
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wall and recurrence of RCC [13,21,25]. In our series, one patient (case 1) with 
squamous metaplasia on the surgical specimen had two recurrences of RCC. He was 
treated using craniotomies three times, including the first operation, and was treated 
with radiation after surgery. The three patients treated conservatively did not require 
surgery during their follow-up periods. The decision to observe an incidentally-found 
RCCs in pediatric patients with normal hormonal values and no chiasmal compression 
seems to be a reasonable one [14]. Further accumulation of RCCs in children is 
required to clarify their natural history with the findings of neuroimaging. 
   Finally, in the aspects of the comparison to the RCCs between children and adults, 
the differences in clinical characteristics can be found in our study as follows; 1) In 
RCCs in children, the sizes of the cysts can increase during the observation period as 
Jahangiri et al. described [14], although the increases are insignificant and their 
symptoms are not progressive. Therefore, the surgical indication should be prudent if 
their symptoms are minor. 2) The suprasellar locations of the cysts might be more 
frequent in children, which require discrimination to the CP. However, other MRI 
evaluation, including the shape, size, and intensity of the cyst, enable us to diagnose as 
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RCCs. Therefore, it can be allowed to conclude that the clinical characteristics of RCCs 
in children are not basically different from those in adults. 
Conclusion 
   In our series, we observed that RCCs are relatively small, have a regular oval shape, 
are hypointense on T2-WI MRI in 55% of cases, and have no calcification. The 
postoperative endocrinological status of patients with RCCs is stable and some cases 
with mild preoperative abnormalities can show improvements after treatment. Although 
surgical intervention can be performed to relieve the symptoms of these patients without 
a high rate of complications, the recurrence rate of RCCs seems to be relatively high. 
Thus, if symptoms are minor, a surgical indication needs to be considered prudently, as 
the symptoms of these patients may be alleviated without progression.
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ACTH; adrenocorticotropic hormone 
ADH; anti-diuretic hormone 
CP; craniopharyngioma 
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Representative case of Rathke cleft cyst. A 10-year-old girl suffered from visual field 
defect. (A) Coronal section of magnetic resonance imaging (MRI) on a T1-weighted 
image (WI) with contrast enhancement showed a regular oval cystic mass located in the 
sella region remarkably compressing the optic chiasm. (B) Sagittal section of MRI with 
T2-WI revealed a hetergenous hypointense signal for the cyst contents.  
 
Figure 2. 
Representative case of cystic craniopharyngioma. A 4-year-old boy presented with 
consciousness disturbance and impaired visual function. (A) Coronal section of MRI on 
T1-WI with contrast enhancement revealed a huge cystic mass extending from the 
suprasellar region toward the intra-third ventricle. (B) Sagittal section of MRI with T2-WI 




A 12-year-old boy suffered from headaches. (A) Coronal section of MRI on T1-WI with 
contrast enhancement shows a hyperintense cystic lesion located in the sella region 
before the first operation (A), after the first recurrence (B), and after the second 
recurrence (C). (D) The pathological examination of the cyst wall revealed the presence 




Table 1.  
Summary of the characteristics of the pediatric patients with Rathke cleft cysts 
 
Table 2.  
Comparison of the patients with Rathke cleft cysts with patients with cystic 
craniopharyngiomas 
Table 1. 
 Sex/Age Symptom Size (mm) MRI Location Pre-OP Post-OP Surgery Recurrence Outcome follow-up (M) 
1. M/12 HA 20 hyper / hyper supra ADH, TSH ACTH, ADH, TSH C / C / C + Improved 84 
2. F/12 HA 20 hyper / hypo supra - - C - Improved 152 
3. M/12 HA 20 hypo / hyper supra GH (ADH) C - Improved 138 
4. M/10 DI 22 hyper / hypo sellar-supra ACTH, ADH ACTH T - Unchanged 89 
5. M/16 VD 33 hypo / hyper sellar-supra GH, TSH GH, TSH C - Improved 115 
6. M/13 HA 15 hyper / hypo sellar-supra ACTH - T / T + Improved 66 
7. F/10 VD 20 hyper / hypo sellar-supra - (ADH) T - Improved 84 
8. F/12 HA 15 hyper / hypo sellar-supra - * - * Unchanged 60 
9. F/18 HA 13 hypo / hyper sellar-supra - * - * Unchanged 50 
10. M/ 5 HA 12 hyper / hypo sellar-supra - * - * Improved 87 
11. F/14 HA 8 hypo / hyper supra - - T - improved 12 
ACTH; adrenocorticotropic hormone, ADH; anti-diuretic hormone, C; craniotomy, DI; diabetes insipidus, EI; endocrinological insufficiencies, GH; growth hormone, HA; headache, hyper; hyperintensity, hypo: 
hypointensity, M; month, MRI; magnetic resonance imaging, OP; operation, supra; suprasellar region, T; transsphenoidal surgery, TSH; thyroid stimulating hormone, VD; visual function deficiency, *; conservative 
treatment was done, (ADH); postoperative transient DI due to ADH deficit 
 
Table 2. 
Variables   Rathke Cleft Cyst  Craniopharyngioma  p value   
          
sex Male : Female  6 : 5  8 : 7  0.951   
          
Age   12.2 ± 3.4  9.3 ± 4.2  0.071   
          
Symptoms HA  9  2  < 0.001 ＊  
 VD  2  14  < 0.001 ＊  
 EI  4  2  0.168   
MRI findings          
Size  (mm) 19.0 (8-33)  34.9 (21-54)  < 0.001 ＊  
          
Intensity T1 hyper 7  4  0.058   
  iso 0  3  0.115   
  hypo 4  8  0.391   
 T2 hyper 4  15  0.001 ＊  
  iso 0  0     
  hypo 6  0  0.001 ＊  
          
Shape  regular  11  5  < 0.001 ＊  
  irregular  0  10     
          
Locations Sellar  7  6  0.234   
 Suprasellar  4  9     
          
Calcification   0  15  < 0.001 ＊  
          
Hydrocephalus   0  5  0.033 ＊  
          
Hormonal Deficits Pre-OP number 5  11  0.149   
  ACTH 2  3  0.908   
  GH 2  8  0.069   
  Gonadotropin 0  9  0.002 ＊  
  TSH 2  0  0.086   
  PRL 0  0     
  ADH 2  0  0.086   
 Post-OP number 3  14  < 0.001 ＊  
  ACTH 2  12  0.020 ＊  
  GH 1  13  < 0.001 ＊  
  Gonadotropin 0  10  < 0.001 ＊  
  TSH 2  11  0.006 ＊  
  PRL 0  5  0.033 ＊  
  ADH 1  9  0.008 ＊  
          
Surgery craniotomy  4  8  0.391   
 transsphenoidal  4  7  0.599   
          
Radiation   1  8  0.013 ＊  
          
Recurrence   2  8  0.184  ＊：P<0.05 
ACTH; adrenocorticotropic hormone, ADH; anti-diuretic hormone, DI; diabetes insipidus, EI; endocrinological insufficiencies, GH; growth hormone, HA; headache, hyper; hyperintensity, hypo: hypointensity, MRI; 
magnetic resonance imaging, OP; operation, supra; suprasellar region, TSH; thyroid stimulating hormone, VD; visual function deficiency 



